Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BCTX

BriaCell Therapeutics (BCTX)

BriaCell Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCTX
DateTimeSourceHeadlineSymbolCompany
09/18/20247:50AMGlobeNewswire Inc.BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer PatientsNASDAQ:BCTXBriaCell Therapeutics Corporation
09/12/20244:05PMGlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $8.5 Million OfferingNASDAQ:BCTXBriaCell Therapeutics Corporation
09/11/202412:09PMGlobeNewswire Inc.BriaCell Therapeutics Announces $8.5 Million OfferingNASDAQ:BCTXBriaCell Therapeutics Corporation
09/11/20247:50AMGlobeNewswire Inc.BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
09/10/20247:50AMGlobeNewswire Inc.BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
09/09/20247:50AMGlobeNewswire Inc.BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:BCTXBriaCell Therapeutics Corporation
08/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
07/18/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
07/18/20247:56AMGlobeNewswire Inc.BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
06/03/20248:00AMGlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024NASDAQ:BCTXBriaCell Therapeutics Corporation
05/30/20248:00AMGlobeNewswire Inc.BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
05/28/20248:00AMGlobeNewswire Inc.BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human StudyNASDAQ:BCTXBriaCell Therapeutics Corporation
05/24/20248:00AMGlobeNewswire Inc.BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024NASDAQ:BCTXBriaCell Therapeutics Corporation
05/17/20244:33PMGlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct OfferingNASDAQ:BCTXBriaCell Therapeutics Corporation
05/15/20248:00AMGlobeNewswire Inc.BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct OfferingNASDAQ:BCTXBriaCell Therapeutics Corporation
04/24/20248:00AMGlobeNewswire Inc.BriaCell Announces Oral and Poster Presentations at ASCO 2024NASDAQ:BCTXBriaCell Therapeutics Corporation
04/10/20248:00AMGlobeNewswire Inc.BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
04/09/20248:00AMGlobeNewswire Inc.BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACRNASDAQ:BCTXBriaCell Therapeutics Corporation
03/07/20248:00AMGlobeNewswire Inc.BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer ImmunotherapiesNASDAQ:BCTXBriaCell Therapeutics Corporation
03/06/20248:00AMGlobeNewswire Inc.BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR ConferenceNASDAQ:BCTXBriaCell Therapeutics Corporation
02/27/20248:00AMGlobeNewswire Inc.BriaCell Provides Update on Alleged Illegal Trading of Public SecuritiesNASDAQ:BCTXBriaCell Therapeutics Corporation
02/07/20248:00AMGlobeNewswire Inc.BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseNASDAQ:BCTXBriaCell Therapeutics Corporation
02/06/20248:30AMGlobeNewswire Inc.Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP ManufacturingNASDAQ:BCTXBriaCell Therapeutics Corporation
02/01/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCTXBriaCell Therapeutics Corporation
01/31/20245:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
01/30/202410:48PMGlobeNewswire Inc.BriaCell Therapeutics Corp. Announces Results of Shareholder MeetingNASDAQ:BCTXBriaCell Therapeutics Corporation
01/22/20245:00PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCTXBriaCell Therapeutics Corporation
01/09/20244:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCTXBriaCell Therapeutics Corporation
01/08/202411:01AMEdgar (US Regulatory)Form SCHEDULE 13G -NASDAQ:BCTXBriaCell Therapeutics Corporation
01/04/20248:45AMGlobeNewswire Inc.BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:BCTX

Your Recent History

Delayed Upgrade Clock